Microneedling With Exosomes for Skin Rejuvenation: Benefits, Evidence & What Patients Should Know

If your goal is healthier-looking, smoother, firmer and more youthful-looking skin, you may have heard about microneedling with exosomes as an emerging approach to skin rejuvenation.

Microneedling has been used for years to improve the appearance of facial wrinkles, acne scars and other textural concerns. More recently, researchers have investigated whether applying an exosome-containing preparation in conjunction with microneedling may provide additional benefits for aging skin.

The early research is interesting—but it is important to distinguish promising clinical evidence from established medical fact.

A 2026 systematic review of microneedling combined with exosome-based approaches found encouraging results across several dermatologic applications, including skin aging, but concluded that larger studies and longer follow-up are still needed to establish the treatment’s long-term safety and effectiveness.

At Azani Medical Spa in Bethlehem, PA, Dr. Monica Gavin and her team take an evidence-based approach to emerging aesthetic treatments, with an emphasis on understanding both their potential benefits and their limitations.

Important FDA distinction: The FDA has legally authorized certain microneedling devices for specific uses, including improving the appearance of facial wrinkles and acne scars. However, the FDA has not cleared microneedling devices for use with another product, meaning the safety and effectiveness of combining a microneedling device with an exosome-containing product have not been reviewed by FDA as a combination treatment.

The FDA also states that there are currently no FDA-approved exosome products.

What Is Skin Rejuvenation?

Skin rejuvenation refers broadly to treatments designed to improve the appearance and quality of aging or photodamaged skin.

Common goals include improving:

• Fine lines and wrinkles
• Uneven skin texture
• Loss of elasticity
• Dullness
• Uneven pigmentation
• Enlarged pores
• Mild skin laxity
• Acne-scar texture
• Overall skin smoothness and radiance

Skin aging is influenced by both intrinsic aging and environmental factors, particularly cumulative ultraviolet exposure. As skin ages, changes occur in collagen, elastin, hydration, pigmentation and the organization of the extracellular matrix.

Because several of these changes occur simultaneously, skin rejuvenation treatments often work by stimulating controlled remodeling rather than simply adding moisture to the skin.

How Does Microneedling Rejuvenate the Skin?

Microneedling uses a device containing multiple tiny needles to create controlled micro-injuries in the skin.

This stimulates a wound-healing response involving processes such as:

1. Controlled inflammation
2. Release of signaling molecules
3. Fibroblast activity
4. Collagen remodeling
5. Formation and organization of new extracellular matrix
6. Gradual improvement in skin texture

The objective is not to injure the skin indiscriminately. Rather, appropriately performed microneedling creates controlled micro-injuries while allowing the skin’s natural repair mechanisms to remodel the treated tissue.

A 2025 systematic review evaluated 21 studies involving 723 patients receiving microneedling for facial rejuvenation. Wrinkles, texture, photoaging and skin laxity were among the most commonly evaluated outcomes. The pooled analysis found that 83% of patients reported satisfaction, although the authors emphasized the lack of standardized outcome measures across studies.

What does that mean for patients?

Microneedling itself has a meaningful evidence base for facial rejuvenation.

The question with exosomes is different:

Can adding an exosome-containing preparation to microneedling improve results beyond microneedling alone?

That is the more important scientific question.

What Are Exosomes?

Exosomes are a type of extracellular vesicle released by cells.

They are microscopic membrane-bound structures involved in intercellular communication and can carry biologically active molecules, including proteins, lipids and nucleic acids.

Researchers are studying whether exosome-based preparations may influence processes involved in:

• Cellular signaling
• Inflammation
• Tissue repair
• Extracellular matrix remodeling
• Collagen production
• Skin barrier function
• Pigmentation
• Wound healing

These biological properties have generated considerable interest in aesthetic medicine.

However, not every product marketed as an “exosome” is equivalent.

Products can differ substantially in:

• Source material
• Manufacturing process
• Purification
• Concentration
• Storage
• Stability
• Characterization
• Intended route of administration
• Whether the preparation actually contains isolated exosomes or a broader extracellular-vesicle preparation

A 2026 scoping review of topical exosome products for skin rejuvenation found substantial heterogeneity among commercially available products and noted that human clinical evidence remains limited.

This is one reason it is inappropriate to assume that results from one published study automatically apply to every product sold or described as an “exosome” treatment.

Why Combine Microneedling With Exosomes?

The rationale for combining the two approaches is relatively straightforward. Microneedling creates controlled microchannels and initiates a wound-healing response.

Exosome-containing preparations are being investigated for their potential biological signaling effects.

The hypothesis is that combining these mechanisms might create an environment that supports more pronounced or efficient skin remodeling.

In other words:

Microneedling provides the controlled stimulus.

The exosome-containing preparation is intended to provide additional biological signaling.

That is the scientific rationale—but a biological rationale does not automatically prove clinical effectiveness. Clinical trials are needed to determine whether the combination actually produces a meaningful improvement for patients.

What Skin Concerns Might Improve?

Research into exosome-assisted skin rejuvenation has examined several aesthetic outcomes.

1. Fine Lines and Wrinkles

Wrinkles are one of the most frequently studied outcomes in facial rejuvenation.

Microneedling can stimulate collagen remodeling, while exosome-based preparations are being investigated for their potential effects on cellular signaling and extracellular matrix processes.

Some clinical studies have reported greater wrinkle improvement with exosome-containing preparations combined with microneedling than with microneedling alone.

However, the evidence remains relatively early and heterogeneous.

A 2023 prospective randomized split-face study involving 28 participants compared microneedling plus an adipose-derived stem-cell exosome-containing solution on one side of the face with microneedling plus saline on the other. The exosome-treated side demonstrated significantly greater improvement on the Global Aesthetic Improvement Scale, along with improvements in measured wrinkles, elasticity, hydration and pigmentation. No serious adverse events were observed during the study.

That study is encouraging because each participant served as their own control.

However, it was still a relatively small study with a 12-week treatment/follow-up period.

2. Skin Texture

Uneven texture can result from:

• Collagen loss
• Photoaging
• Acne scarring
• Enlarged pores
• Irregular epidermal and dermal remodeling

Microneedling is already used to improve the appearance of certain textural concerns. Researchers are investigating whether exosome-containing preparations may enhance this remodeling process.

A 2025 split-face observational study involving nine women reported greater improvements in texture, hydration, elasticity and pigmentation on exosome-treated sides following energy-based treatments. The authors reported particularly notable changes with microneedling plus exosomes, but the small sample size means the results should be considered preliminary.

3. Hydration

Skin hydration is another outcome frequently measured in exosome studies.

In the 2023 randomized split-face study, objective measurements showed greater improvement in hydration on the side treated with microneedling plus an adipose-derived stem-cell exosome-containing solution compared with microneedling and saline.

Improved hydration can make skin appear:

• Smoother
• Plumper
• More luminous
• Less crepey

However, hydration measurements should not be confused with permanent structural rejuvenation.

A temporary improvement in skin hydration is not necessarily equivalent to increased collagen or long-term reversal of skin aging.

4. Uneven Pigmentation

Pigmentation is another area of interest.

The 2023 randomized split-face study reported greater improvement in pigmentation on the exosome-treated side.

Other studies have also reported changes in pigmentation-related measurements.

However, pigmentation disorders are complex. Melasma, post-inflammatory hyperpigmentation, photodamage and other pigmentary conditions have different causes and may require very different treatment strategies.

Therefore, exosome-assisted microneedling should not automatically be considered a treatment for every pigmentation disorder.

5. Skin Elasticity

Loss of elasticity is a major component of visible facial aging.

Collagen and elastin changes contribute to:

• Fine lines
• Wrinkling
• Skin laxity
• Loss of firmness
• Changes in facial texture

The 2023 randomized split-face trial reported greater improvement in measured elasticity on the exosome-treated side compared with microneedling plus saline.

These findings support continued investigation but do not yet establish the degree or duration of elasticity improvement that can be expected in routine clinical practice.

6. Enlarged Pores and Overall Skin Quality

Pore visibility and overall skin quality have also been evaluated in more recent research.

A particularly recent 2026 randomized split-face study evaluated radiofrequency microneedling followed by a topical extracellular-vesicle preparation versus radiofrequency microneedling alone in 60 adults.

At 12 weeks, wrinkle improvement favored the extracellular-vesicle-treated side. Texture, pore visibility, hydration, pigmentation and aesthetic improvement scores also numerically favored the combination side. However, the researchers specifically cautioned that the study was unblinded, follow-up was only 12 weeks, and histologic or molecular biomarkers were not included.

This is an important addition to the evidence because it suggests a possible incremental benefit—but it does not establish long-term effectiveness.

What Does the Research Actually Show?

The evidence is promising but preliminary.

That distinction is important.

A 2026 systematic review of microneedling with exosomes identified eight studies for its final narrative synthesis. The studies were relatively small, ranging from three to 60 participants, and examined different conditions and treatment protocols.

The review concluded that microneedling combined with exosomes shows promise but that larger studies and longer follow-up are needed to determine the treatment’s safety and effectiveness more definitively.

A separate 2026 scoping review examining topical exosomes for skin rejuvenation found only a limited body of human clinical research and substantial variation among commercially available preparations.

The practical interpretation:

There is enough evidence to justify scientific interest.

There is not yet enough evidence to claim that exosome microneedling is a proven superior treatment for skin rejuvenation.

That distinction matters when evaluating marketing claims.

The Most Important Human Study: The 2023 Randomized Split-Face Trial

One of the more useful studies to date was the 2023 randomized split-face trial. Twenty-eight participants underwent three treatment sessions at three-week intervals.

One side of the face received: Microneedling + human adipose tissue stem-cell-derived exosome-containing solution

The other side received: Microneedling + saline

The study found significantly better Global Aesthetic Improvement Scale scores on the exosome-treated side.

Objective measurements also demonstrated greater improvements in:

• Wrinkles
• Elasticity
• Hydration
• Pigmentation

No serious adverse events were observed.

This is stronger evidence than an uncontrolled before-and-after study because the comparison was performed within the same individuals. Nevertheless, the study was relatively small and short. It should therefore be viewed as encouraging evidence rather than definitive proof.

What Did the 2026 Research Add?

The evidence base is expanding.

A 2026 retrospective analysis evaluated 40 patients who received microneedling combined with an exosome-containing skin booster. The investigators reported favorable patient-reported and aesthetic outcomes, with mostly mild transient adverse effects.

Because the study was retrospective and lacked a randomized control group, however, it cannot establish how much of the observed improvement was caused by the exosome-containing preparation versus microneedling itself, natural variation or other factors.

The newer 2026 randomized split-face study involving radiofrequency microneedling and a topical extracellular-vesicle preparation provides additional evidence of a possible incremental benefit, but its unblinded design and 12-week follow-up also limit the conclusions that can be drawn.

Taken together, these studies make the subject scientifically interesting—but they do not eliminate the need for larger, well-controlled trials.

What Is the FDA Status?

This is one of the most important questions patients should ask.

Microneedling Devices

The FDA has legally authorized certain microneedling devices for specific uses, including improving the appearance of facial wrinkles and facial acne scars in appropriate patients. Authorization applies to particular devices and particular intended uses—not to every microneedling device or every possible application.

Exosome Products

The FDA states that there are currently no FDA-approved exosome products.

The FDA also regulates exosome products and warns consumers about products marketed without appropriate FDA authorization.

Combining Microneedling With Another Product

The FDA specifically states that microneedling devices have not been cleared for use with another product. Therefore, FDA has not reviewed the safety or effectiveness of combining an FDA-authorized microneedling device with an exosome-containing preparation as a combination treatment.

Why this distinction matters

A clinic can use an FDA-authorized microneedling device for an authorized indication without that meaning that the exosome product or the combination procedure is FDA-approved.

Patients should be cautious whenever advertising blurs those distinctions.

Questions to Ask Before an Exosome Microneedling Treatment

If you are considering this type of treatment, ask the provider:

1. What exactly is the product?

Ask for the product’s complete name and manufacturer.

2. What is the source of the preparation?

For example, is it human-derived, plant-derived, synthetic, or another extracellular-vesicle preparation?

3. How is it manufactured and characterized?

The word “exosome” by itself tells you very little about product quality.

4. Has FDA authorized or approved this specific product?

Do not accept vague phrases such as “FDA registered,” “FDA compliant,” or “FDA certified” as substitutes for FDA approval or authorization.

5. Is the microneedling device FDA-authorized for its intended use?

The FDA recommends that healthcare providers use FDA-authorized microneedling devices and verify their regulatory status.

6. What evidence supports this particular preparation?

A study performed using one product does not automatically establish the effectiveness of another product.

7. What are the risks?

Ask specifically about infection, irritation, inflammatory reactions, pigmentation changes, scarring and other complications.

Who May Consider Microneedling With Exosomes?

A consultation may be appropriate for adults interested in improving the appearance of:

• Fine lines
• Mild to moderate photoaging
• Uneven texture
• Dull or tired-looking skin
• Mild loss of elasticity
• Certain types of acne-scar texture
• Uneven pigmentation
• Overall skin quality

However, suitability depends on the individual’s skin type, medical history, medications, active skin conditions and treatment goals.

A medical evaluation is particularly important when a patient has an active infection, significant inflammatory skin disease, a history of abnormal scarring or another condition that could affect healing.

When Might Microneedling Alone Be Enough?

This is an important question.

Because microneedling itself has evidence supporting facial rejuvenation, not every patient necessarily needs an adjunctive product.

A 2025 systematic review found that microneedling alone was associated with high patient satisfaction and generally low rates of reported adverse effects across the studies evaluated.

For some patients, the simplest evidence-based approach may be the best starting point.

The decision to add an emerging adjunct should depend on:

• The patient’s goals
• The severity of the concern
• Previous treatments
• Skin characteristics
• Available evidence
• Product quality
• Risk tolerance
• Cost

A responsible treatment plan should not assume that adding more components automatically produces a better result.

How Many Treatments Are Needed?

There is currently no universally established treatment schedule for microneedling with exosomes.

Published studies have used different protocols.

For example, the 2023 randomized split-face trial used three treatments spaced three weeks apart.

Other studies have used different treatment intervals and different numbers of sessions.

Therefore, treatment frequency should be individualized rather than presented as a universally proven protocol.

What Is Recovery Like?

Recovery depends on the microneedling device, needle depth, treatment intensity, skin type and whether another treatment or topical preparation is used.

After conventional microneedling, temporary effects may include:

• Redness
• Mild swelling
• Tightness
• Warmth
• Sensitivity
• Mild scaling

A 2025 systematic review of microneedling for facial rejuvenation found transient erythema to be among the most commonly reported adverse effects, with other reported effects including scaling, burning and itching.

Your provider should give you specific post-treatment instructions regarding sun exposure, skin-care products and when to resume active ingredients.

Microneedling With Exosomes vs. Other Skin-Rejuvenation Treatments

Key takeaway: There is no single “best” skin-rejuvenation treatment for everyone. The goal of a consultation is to identify the specific concern being treated and determine whether microneedling, exosomes, injectables, laser/energy-based treatments, peels, skin care, or a combination approach is most appropriate.

The Bottom Line

Microneedling with exosome-containing preparations is one of the more interesting emerging approaches to skin rejuvenation, but it is not yet a fully established treatment.

Microneedling itself has a substantial clinical literature supporting its use for improving the appearance of facial skin aging, including wrinkles and texture.

Early studies suggest that adding an exosome-containing preparation may provide additional improvements in outcomes such as:

• Wrinkles
• Hydration
• Elasticity
• Texture
• Pigmentation
• Overall aesthetic appearance

The 2023 randomized split-face trial is particularly encouraging, while newer 2026 research continues to investigate whether an incremental benefit exists.

But the overall evidence remains limited by relatively small studies, heterogeneous products and protocols, short follow-up periods and a lack of large, standardized randomized trials.

And importantly, the FDA states that there are currently no FDA-approved exosome products. The FDA has also not cleared microneedling devices for use with another product.

For patients considering this treatment, the most important questions are therefore not simply “Do exosomes work?” but:

What exactly is being used?

What evidence supports that specific product?

What has the FDA actually authorized?

And is adding the product likely to provide enough potential benefit to justify the additional cost and uncertainty?

Those are the questions a thoughtful, physician-led consultation should address.

Considering Microneedling With Exosomes in Bethlehem, PA?

If you are considering skin rejuvenation with microneedling, a personalized consultation can help determine whether microneedling alone or an adjunctive approach is appropriate for your skin and goals.

At Azani Medical Spa in Bethlehem, PA, Dr. Monica Gavin and her team use an individualized approach to aesthetic treatment planning.

Learn more about microneedling with exosomes at Azani Medical Spa and discuss your goals, expected benefits, limitations and treatment options during a consultation.

Medical Disclaimer

This article is intended for general educational purposes and does not constitute individualized medical advice, diagnosis or treatment. Results vary among individuals. Microneedling and exosome-containing preparations may have risks, and not every patient is an appropriate candidate. Treatment decisions should be made following an individualized evaluation by a qualified healthcare professional.

Content Update

Last medically reviewed/updated: September 2026